Antibiotics: Research

Department of Health written question – answered on 11th December 2017.

Alert me about debates like this

Photo of Lord Crathorne Lord Crathorne Conservative

To ask Her Majesty's Government what plans they have to support small UK companies which are researching and trying to produce new antibiotics, in particular through the use of market entry rewards.

Photo of Lord O'Shaughnessy Lord O'Shaughnessy The Parliamentary Under-Secretary of State for Health

The Government has invested in a range of research to address antimicrobial resistance (AMR). Specific investments aimed at small and medium sized enterprises include a competition call worth £4 million in 2016/17 launched by Innovate UK to reinvigorate AMR research and innovation networks in the United Kingdom. This call particularly focused on the need for collaborative working with industry, including small and medium sized enterprises, to bring products to market. The UK is also spending £50 million in a Global AMR Innovation Fund which aims to invest in global research and development for the benefit of people living in low- and middle-income countries. As part of this, it will consider how to provide access to finance for those researchers who struggle to access traditional funding sources, including small and medium sized enterprises.

In response to the independent review on AMR chaired by Lord O’Neill, the Government committed to strengthening support for market entry rewards in international fora including the G7 and G20 to address market failure in antibiotics. The Department is currently working through the G20 to make tangible progress in developing market incentives.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.